These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 6119215

  • 1. Changes in catalepsy and receptor sensitivity following chronic neuroleptic treatment.
    Allikmets LH, Zarkovsky AM, Nurk AM.
    Eur J Pharmacol; 1981 Oct 22; 75(2-3):145-7. PubMed ID: 6119215
    [No Abstract] [Full Text] [Related]

  • 2. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ, Korf J.
    Psychopharmacology (Berl); 1986 Oct 22; 90(1):54-7. PubMed ID: 3094062
    [Abstract] [Full Text] [Related]

  • 3. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T, Sharp T, Ungerstedt U.
    Eur J Pharmacol; 1984 Oct 30; 106(1):27-37. PubMed ID: 6085051
    [Abstract] [Full Text] [Related]

  • 4. The effect of bradykinin on central dopamine receptors.
    Przesmycki K, Kleinrok Z.
    Pol J Pharmacol Pharm; 1976 Oct 30; 28(6):673-8. PubMed ID: 1034925
    [Abstract] [Full Text] [Related]

  • 5. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
    Bartholini G.
    Adv Biochem Psychopharmacol; 1977 Oct 30; 16():607-11. PubMed ID: 18902
    [No Abstract] [Full Text] [Related]

  • 6. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF, Sanberg PR, Norman AB.
    Brain Res; 1988 May 31; 450(1-2):403-7. PubMed ID: 2969764
    [Abstract] [Full Text] [Related]

  • 7. Effect of drugs on metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L.
    Br J Pharmacol; 1975 Mar 31; 53(3):460P. PubMed ID: 1169083
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Conditional tolerance to haloperidol-induced catalepsy: striatal dopamine receptor supersensitivity is a possible explanation.
    Hoffman DC, Beninger RJ.
    Psychopharmacology (Berl); 1988 Mar 31; 95(1):142-5. PubMed ID: 3133695
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM, Matvienko OA, Nurk AM.
    Biull Eksp Biol Med; 1984 Oct 31; 98(10):444-6. PubMed ID: 6541951
    [Abstract] [Full Text] [Related]

  • 13. The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.
    Robinson SE, Berney S, Mishra R, Sulser F.
    Psychopharmacology (Berl); 1979 Aug 08; 64(2):141-7. PubMed ID: 40288
    [No Abstract] [Full Text] [Related]

  • 14. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K, Karcz M, Wardas J, Wolfarth S.
    Eur J Pharmacol; 1990 Jul 03; 182(2):327-34. PubMed ID: 1975782
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of muscimol, a central GABA receptor agonist, on the catalepsy, striatal homovanillic acid increase, and analgesia induced by pilocarpine in rats.
    Naik SR, Kelkar MR, Amladi SR, Sheth UK.
    Psychopharmacology (Berl); 1981 Jul 03; 74(4):393-4. PubMed ID: 6794090
    [Abstract] [Full Text] [Related]

  • 17. The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis.
    Worms P, Willigens MT, Continsouza-Blanc D, Lloyd KG.
    Eur J Pharmacol; 1985 Jul 11; 113(1):53-9. PubMed ID: 2864264
    [Abstract] [Full Text] [Related]

  • 18. Interaction of benzodiazepines with neuroleptics at central dopamine neurons.
    Keller HH, Schaffner R, Haefely W.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul 11; 294(1):1-7. PubMed ID: 12477
    [Abstract] [Full Text] [Related]

  • 19. Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.
    Scatton B.
    J Pharmacol Exp Ther; 1982 Jan 11; 220(1):197-202. PubMed ID: 6118430
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E, Ceci A, Spinelli R, Samanin R.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2387-91. PubMed ID: 2886127
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.